Showing 2561-2570 of 4063 results for "".
- Samsung Bioepis Presents Data from its Ophthalmology Biosimilar Portfolio at AAO 2022 Annual Meetinghttps://modernod.com/news/samsung-bioepis-presents-data-from-its-ophthalmology-biosimilar-portfolio-at-aao-2022-annual-meeting/2481121/Samsung Bioepis announced that three scientific abstracts relating to its ophthalmology biosimilar portfolio will be presented at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting being held from September 30 to October 3, 2022 in Chicago. The phase 3 study on SB15, a
- Ocular Therapeutix To Present Data at the American Academy of Ophthalmology (AAO) 2022 Annual Meetinghttps://modernod.com/news/ocular-therapeutix-to-present-data-at-the-american-academy-of-ophthalmology-aao-2022-annual-meeting/2481110/Ocular Therapeutix announced multiple presentations at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting being held September 30-October 3, 2022 at McCormick Place Convention Center in Chicago. “We have a big presence at AAO this year with many presentations dis
- Amydis Enrolls First Participants in PROBE, a Phase 1/2a Trial Evaluating a Novel Retinal Tracer in People with Amyotrophic Lateral Sclerosis or Parkinson’s Diseasehttps://modernod.com/news/amydis-announces-enrollment-of-first-participants-in-probe-a-phase-12a-trial-evaluating-a-novel-retinal-tracer-in-people-with-amyotrophic-lateral-sclerosis-or-parkinsons-disease/2481109/Amydis announced dosing of the first patients in the company’s phase 1/2a trial evaluating AMDXP-2011P, a proprietary small molecule retinal imaging agent “retinal tracer” targeting deposits of alpha synuclein (ASYN) and the TAR DNA-binding protein 43 (TDP-43) in patients w
- Sight Sciences OMNI Surgical System to Be Featured in Multiple Presentations at the 2022 ESCRShttps://modernod.com/news/sight-sciences-omni-surgical-system-to-be-featured-in-multiple-presentations-at-the-2022-escrs/2481099/Sight Sciences announced that its OMNI Surgical System will be featured in seven clinical presentations at the 2022 European Society of Cataract & Refractive Surgeons (ESCRS) meeting in Milan, Italy from September 16-20. At Sight Sciences Booth A2
- Envision University Sets Agenda for Virtual Fall Conference 2022https://modernod.com/news/envision-university-sets-agenda-for-virtual-fall-conference-2022/2481075/Organizers of the Envision Conference through Envision University have set the agenda for Envision Virtual Fall Conference with sessions and opportunities for professionals in the vision rehabilitation field. The conference will be October 7-8, 2022, via livestream webinar. Envision Conference is
- Glaukos Announces More Than 1 Million iStent Devices Implanted Worldwidehttps://modernod.com/news/glaukos-announces-more-than-1-million-istent-devices-implanted-worldwide/2481064/Glaukos announced that it has reached a milestone with its iStent family of technologies having now been implanted in more than 1 million procedures worldwide. “One million iStents implanted is a tremendous accomplishment and I’m grate
- Pixium Vision Announces Participation in Upcoming Scientific Conferences in September 2022https://modernod.com/news/pixium-vision-announces-participation-in-upcoming-scientific-conferences-in-september-2022/2481049/Pixium Vision announced that senior management will participate in the following scientific conferences during September 2022: 22nd EURETINA Congress, September 1-4, Hamburg & Virtual Lloyd Diamond, CEO; Ralf Hornig, PhD, and director of clinic
- Apellis Announces 24-Month Results in Phase 3 Studies Examining Pegcetacoplan in Geographic Atrophy (GA)https://modernod.com/news/apellis-announces-24-month-results-showing-increased-effects-over-time-with-pegcetacoplan-in-phase-3-derby-and-oaks-studies-in-geographic-atrophy-ga/2481045/Apellis Pharmaceuticals announced topline data at 24 months showing increased effects over time with intravitreal pegcetacoplan, an investigational, targeted C3 therapy, in the phase 3 DERBY and OAKS studies in geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
- Show Organizers Announce Reimagined Floor Plan for Vision Expo East 2023https://modernod.com/news/show-organizers-announce-reimagined-floor-plan-for-vision-expo-east-2023/2481037/The Vision Council and RX, co-organizers of Vision Expo, shared plans for a reimagined show floor layout that will debut at Vision Expo East 2023, taking place March 16–19 at the Javits Center in New York City. The new layout will feature all of Vision Expo’s Show Fl
- Alcon’s Sue-Jean Lin Named 2022 US National CIO of the Yearhttps://modernod.com/news/alcons-sue-jean-lin-named-2022-us-national-cio-of-the-year/2481019/Alcon announced that Sue-Jean Lin, Senior Vice President and Chief Information and Transformation Officer, was awarded the 2022 U.S. National CIO of the Year ORBIE Award in the "Global" category for multinational companies over $5 billion in annual revenue. This follows her recognition